Osteologie, Table of Contents Osteologie 2011; 20(04): 6-7DOI: 10.1055/s-0037-1620020 Vitamin D Schattauer GmbH Literatur M. Pfeifer Recommend Article Abstract Buy Article Full Text References Literatur 1 Pfeifer M, Minne HW. Zum Einfluss von Vitamin D und Kalzium auf die muskuloskelettale Gesundheit. Osteologie 2008; 17: 39-45. 2 Jackson RD, LaCroix AZ, Gass M. et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006; 354: 669-683. 3 Bischoff-Ferrari HA. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 2007; 18: 401-407. 4 Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in elderly men and women. N Engl J Med 1997; 337: 670-676. 5 Chapuy MC, Arlot ME, Duboeuf F. et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-1642. 6 Pfeifer M, Begerow B, Minne HW. et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000; 15: 1113-1118. 7 Bischoff HA, Stähelin HB, Dick W. et al. Effects of vitamin D and calcium supplementation on falls: a randomized trial. J Bone Miner Res 2003; 18: 343-351. 8 Grant AM, Avenell A, Campbell MK. et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised evaluation of calcium or vitamin D, RECORD): a randomised placebo-controlled trail. Lancet 2005; 365: 1-8. 9 Porthouse J, Cockayne S, King C. et al. Randomised controlled trail of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. Br Med J 2005; 330: 1003-1009. 10 Pfeifer M, Begerow B, Minne HW. et al. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle in communitydwelling older individuals. Osteoporos Int 2009; 20: 315-322. 11 Tinetti ME, Doucette J, Claus E, Marottoli R. Risk factors for serious injury durino falls by older persons in the community. J Am Geriatr Soc 1995; 43: 1214-1221. 12 Bischoff-Ferrari HA, Willet WC, Wong JB. et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Ann Intern Med 2009; 169: 551-561. 13 Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB. et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. Br Med J 2009; 339: b3692. 14 Trivedi DP, Doll R, Khaw KT. Effect of four monthly vitamin D3 (cholecalciferol) supplementation on fracture and mortality in men and women living in the community: randomised double blind controlled trial. Br Med J 2003; 326: 469-474. 15 Chapuy MC, Pamphile R, Paris E. et al. Combined calcium and vitamin D3 supplemenation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos I Study. Osteoporos Int 2002; 13: 257-264. 16 Lyons RA, Johansen A, Brophy S. et al. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos Int 2007; 18: 811-818. 17 Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferoltreatment for three years on hip fractures in elderly women. Br Med J 1994; 308: 1081-1083. 18 Flicker L, McInnis RJ, Stein MS. et al. Should older people in residential care receive vitamin D to prevent falls? Results of a randomised trial. J Am Geriatr Soc 2005; 53: 1881-1888. 19 Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002; 13: 187-194. 20 Holick MF. Non-calcemic actions of dihydroxyvitamin D3 and clinical applications. aBone 1995; 17: S107-S111. 21 Dukas L, Schacht E, Mazor Z, Stähelin HB. Treatment with alfacalcidol in elderly people decreases the high risk of falls associated with a low creatinine clearance of < 65 ml/min. Osteoporos Int 2005; 16: 198-203. 22 Dukas L, Bischoff HA, Lindpaintner LS. et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004; 52: 230-236. 23 Gallagher JC. The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol 2004; 89: 497-501. 24 Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13: 719-764. 25 Norman AW, Nemere I, Zhou LX. et al. 1,25(OH)2D, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992; 41: 231-240. 26 Morrison N. Vitamin D receptor gene variants and osteoporosis: a contributor to the polygenetic control of bone density. In: Feldman B, Glorieux FH, Pike JW. eds. aVitamin D. San Diego: Academic Press; 1997: 713-731. 27 Geusens P, Vandevyver C, Vanhoof J. et al. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly non-obese women. J Bone Miner Res 1997; 12: 2082-2088. 28 de Boland AR, Boland RL. Non-genomic signal transduction of vitamin D in muscle cells. Cell Signal 1994; 06: 717-724. 29 Prineas W, Stuart-Mason A, Henson RA. Myopathy and neuropathy associated with osteomalacia. Br Med J 1965; I: 1034-1036. 30 Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976; I: 626-629. 31 Chalmers J, Conacher WDH, Gardner DL, Scott PJ. Osteomalacia - a common disease in elderly women. J Bone Joint Surg Br 1967; 49: 403-423. 32 Gloth FM, Lindsay JM, Zelesnick LB, Greenough WB. Can vitamin D deficiency produce an unusual pain syndrome?. Arch Intern Med 1991; 151: 1662-1664. 33 Skaria J, Katiyar BC, Srivastava TP, Dube B. Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 1975; 51: 37-58. 34 Ronin DI, Wu Y, Sahgal V, MacLean IC. Intractable muscle pain syndrome, osteomalacia, and axonopathy in long-term use of phenytoin. Arch Phys Med Rehabil 1991; 72: 755-758. 35 Mallette LE, Patten BM, Engel WK. Neuromuscular disease in secondary hyperparathyroidism. Ann Intern Med 1975; 82: 474-483. 36 Yoshikawa S, Nakamura T, Tanabe H, Imamura T. Osteomalacic myopathy. Endocrinol Jpn 1979; 26: 65-72. 37 Jones DA, Round JM. Skeletal muscle in health and disease. Manchester: Manchester University Press; 1992: 52-60. 38 McConas AJ. Skeletal muscle: form and function. Champaign: Human Kinetics; 1996: 62-65. 39 Pfeifer M, Minne HW. Vitamin D and hip fracture. Trends Endocrinol Metab 1999; 10: 417-420. 40 Stein MS, Wark JD, Scherer SC. et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc 1999; 47: 1195-1201. 41 Bischoff-Ferrari HA, Borchers M, Gudat F. et al. Vitamin D receptor expression in human muscle tissue decreases with age. 42 Curry OB, Basten JF, Francis MJ, Smith R. Calcium uptake by sarcoplasmatic reticulum of muscle from vitamin D deficient rabbits. Nature 1974; 249: 83-84. 43 Birge SJ, Haddad JG. 25-Hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 1975; 56: 1100-1107. 44 Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986; 07: 434-448. 45 Boland R, deBoland AR, Ritz E, Hasselbach W. Effect of 1,25-dihydroxycholecalciferol on sarcoplasmatic reticulum calcium transport in strontium fed rats. Calcif Tiss Int 1983; 35: 190-194. 46 Pointon JJ, Francis MJ, Smith R. Effect of vitamin D deficiency on sarcoplasmatic reticulum function and troponin C concentration of rabbit skeletal muscle. Clin Sci 1979; 57: 257-263. 47 Pleasure D, Wyszynski B, Summer A. et al. Skeletal muscle calcium metabolism and contractile force in vitamin D-deficient chicks. J Clin Invest 1979; 64: 1157-1167. 48 Simpson R, Thomas G, Arnold A. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J BiolChem 1985; 260: 8882-8891. 49 Bischoff-Ferrari HA, Dawson-Hughes B, Platz A. et al. Effect of high dosage cholecalciferol and extended physiotherapy on complications after hip fractures. Arch Intern Med 2010; 170: 813-820. 50 Bischoff-Ferrari HA, Shao A, Dawson-Hughes B. et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 2010; 21: 1121-1132. 51 Ginde AA, Mansbach JM, Camargo CA. Association between serum 25 hydroxyvitamin D level and upper respiratory tract infection in NHANES III. Arch Intern Med 2009; 169: 384-390. 52 http://www.iom.edu/vitamind (November 2010). 53 Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient?. J Bone Miner Res 2011; 26: 455-457. 54 Priemel M, von Domarus C, Klatte TO. et al. Bone mineralization defects and vitamin D deficiency; histomorphometric analysis of iliac creast biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010; 25: 305-312. 55 Reid IR, Avenell A. Evidence-based policy on dietary calcium and vitamin D. J Bone Miner Res 2011; 26: 452-454. 56 Bolland MJ, Avenell A, Baron JA. et al. Effect of calcium supplements on the risk of myocardial infarction and cardiovascular events: a meta-analysis. Br Med J 2010; 341: c3691. 57 Tang BMP. Does calcium supplementation really cause more hip fractures?. Osteoporos Int 2009; 20: 1119-1123. 58 Burckhardt P, Amling M, Dobnig H. et al. Stellungnahme des DVO: Diskussion über die optimale Dosis von Vitamin D. Osteologie 2011; 20: 149-151.
